Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy

References

• HIV/AIDS: data and statistics [webpage on the Internet]GenevaWorld Health Organization2013 Available from: http://www.who.int/hiv/data/en/index.htmlAccessed April 26, 2013
   Google Scholar
• Barré-SinoussiFChermannJCReyFIsolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)Science1983220459986887110.1126/science.61891836189183
   PubMed Web of Science ®Google Scholar
• GalloRCSalahuddinSZPopovicMFrequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDSScience1984224464850050310.1126/science.62009366200936
   PubMed Web of Science ®Google Scholar
• SarngadharanMGPopovicMBruchLSchupbachJGalloRCAntibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDSScience1984224464850650810.1126/science.63243456324345
   PubMed Web of Science ®Google Scholar
• PetriccianiJCLicensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificityAnn Intern Med1985103572672910.7326/0003-4819-103-5-7262996408
   PubMed Web of Science ®Google Scholar
• SchorrJBBerkowitzACummingPDKatzAJSandlerSGPrevalence of HTLV-III antibody in American blood donorsN Engl J Med1985313638438510.1056/NEJM1985080831306103859750
   PubMed Web of Science ®Google Scholar
• BiggarRJThe AIDS problem in AfricaLancet198618472798310.1016/S0140-6736(86)90728-22867324
   PubMed Web of Science ®Google Scholar
• DowningRGOttenRAMarumEOptimizing the delivery of HIV counseling and testing services: the Uganda experience using rapid HIV antibody test algorithmsJ Acquir Immune Defic Syndr Hum Retrovirol199818438438810.1097/00042560-199808010-000119704945
   PubMedGoogle Scholar
• PaiNPTulskyJPCohanDColfordJMJrReingoldALRapid point-of-care HIV testing in pregnant women: a systematic review and meta-analysisTrop Med Int Health200712216217310.1111/j.1365-3156.2006.01812.x17300622
   PubMed Web of Science ®Google Scholar
• HIV Assays: Operational Characteristics (Phase 1) Report 14: Simple/Rapid TestsGenevaWorld Health Organization2004
   Google Scholar
• CohenRLynchSBygraveHAntiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two yearsJ Int AIDS Soc2009122310.1186/1758-2652-12-2319814814
   PubMed Web of Science ®Google Scholar
• BemelmansMvan den AkkerTFordNProviding universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS careTrop Med Int Health201015121413142010.1111/j.1365-3156.2010.02649.x20958897
   PubMed Web of Science ®Google Scholar
• ChettyVMoodleyDChuturgoonAEvaluation of a 4th generation rapid HIV test for earlier and reliable detection of HIV infection in pregnancyJ Clin Virol201254218018410.1016/j.jcv.2012.02.02122445263
   PubMed Web of Science ®Google Scholar
• WessmanMJTheilgaardZKatzensteinTLDetermination of HIV status of infants born to HIV-infected mothers: a review of the diagnostic methods with special focus on the applicability of p24 antigen testing in developing countriesScand J Infect Dis201244320921510.3109/00365548.2011.62756922074445
   PubMed Web of Science ®Google Scholar
• CiaranelloALParkJERamirez-AvilaLFreedbergKAWalenskyRPLeroyVEarly infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventionsBMC Med201195910.1186/1741-7015-9-5921599888
   PubMed Web of Science ®Google Scholar
• Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2010GenevaWorld Health Organization2010
   Google Scholar
• GallantJEStaszewskiSPozniakALEfficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trialJAMA2004292219120110.1001/jama.292.2.19115249568
   PubMed Web of Science ®Google Scholar
• GallantJEDeJesusEArribasJRStudy 934 GroupTenofovir DF, emtricitabine, and efavirenz vs zidovudine, lamivudine, and efavirenz for HIVN Engl J Med2006354325126010.1056/NEJMoa05187116421366
   PubMed Web of Science ®Google Scholar
• ClotetBBellosNMolinaJMPOWER 1 and 2 study groupsEfficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trialsLancet200736995681169117810.1016/S0140-6736(07)60497-817416261
   PubMed Web of Science ®Google Scholar
• van SighemAIGrasLAReissPBrinkmanKde WolfFATHENA national observational cohort studyLife expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individualsAIDS201024101527153510.1097/QAD.0b013e32833a394620467289
   PubMed Web of Science ®Google Scholar
• TanserFBarnighausenTGrapsaEZaidiJNewellMLHigh coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South AfricaScience2013339612296697110.1126/science.122816023430656
   PubMed Web of Science ®Google Scholar
• DattaPEmbreeJEKreissJKMother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi StudyJ Infect Dis199417051134114010.1093/infdis/170.5.11347963705
   PubMed Web of Science ®Google Scholar
• [No authors listed]Mother-to-child transmission of HIV infection. The European Collaborative StudyLancet198828619103910432903276
   PubMed Web of Science ®Google Scholar
• StringerJSRouseDJSinkalaMNevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatusLancet200336293981850185310.1016/S0140-6736(03)14907-014654326
   PubMed Web of Science ®Google Scholar
• LallemantMJourdainGLe CoeurSSingle-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in ThailandN Engl J Med2004351321722810.1056/NEJMoa03350015247338
   PubMed Web of Science ®Google Scholar
• Dryden-PetersonSJayeobaOHughesMDHighly active anti-retroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, BotswanaJ Acquir Immune Defic Syndr201158335335710.1097/QAI.0b013e31822d406321792062
   PubMed Web of Science ®Google Scholar
• DonnellDBaetenJMKiarieJPartners in Prevention HSV/HIV Transmission Study TeamHeterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysisLancet201037597312092209810.1016/S0140-6736(10)60705-220537376
   PubMed Web of Science ®Google Scholar
• ZaidiJGrapsaETanserFNewellMLBarnighausenTDramatic increases in HIV prevalence after scale-up of antiretroviral treatment: a longitudinal population-based HIV surveillance study in rural kwazulu-natalAIDS Epub510201310.1097/QAD.0b013e328362e83223669155
   PubMed Web of Science ®Google Scholar
• WHOConsolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach Available from http://www.who.int/hiv/pub/guidelines/arv2013/download/en/Accessed August 1, 2013
   Google Scholar
• CelumCHallettTBBaetenJMHIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impactJ Infect Dis2013208218919110.1093/infdis/jit15423570851
   PubMed Web of Science ®Google Scholar
• GranichRCrowleySVitoriaMHighly active antiretroviral treatment for the prevention of HIV transmissionJ Int AIDS Soc201013110.1186/1758-2652-13-120205768
   PubMed Web of Science ®Google Scholar
• GranichRMGilksCFDyeCDe CockKMWilliamsBGUniversal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelLancet20093739657485710.1016/S0140-6736(08)61697-919038438
   PubMed Web of Science ®Google Scholar
• Guidance on couples HIV testing and counselling – including antiretroviral therapy for treatment and prevention in serodiscordant couplesGenevaWorld Health Organization2012
   Google Scholar
• CohenMSChenYQMcCauleyMPrevention of HIV-1 infection with early antiretroviral therapyN Engl J Med2011365649350510.1056/NEJMoa110524321767103
   PubMed Web of Science ®Google Scholar
• OsborneBJShethPMYiTJImpact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semenJ Infect Dis201320781226123410.1093/infdis/jit02623329849
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration [webpage on the Internet] Available from www.fda.govAccessed July 22, 2013
   Google Scholar
• CarterRJDuganKEl-SadrWMCD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settingsJ Acquir Immune Defic Syndr201055340441010.1097/QAI.0b013e3181e73f4b20595905
   PubMed Web of Science ®Google Scholar
• TorpeyKLarteyMAmenyahRInitiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need?Int J STD AIDS200920639539810.1258/ijsa.2008.00833319451324
   PubMed Web of Science ®Google Scholar
• EmmettSDCunninghamCKMmbagaBTPredicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional studyJ Acquir Immune Defic Syndr201054436837520216225
   PubMed Web of Science ®Google Scholar
• BaveewoSSsaliFKaramagiCValidation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in UgandaPLoS One201165e1908910.1371/journal.pone.001908921589912
   PubMed Web of Science ®Google Scholar
• AsboeDAitkenCBoffitoMBHIVA Guidelines SubcommitteeBritish HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011HIV Med201213114410.1111/j.1468-1293.2011.00971.x22171742
   PubMed Web of Science ®Google Scholar
• TangMWShaferRWHIV-1 antiretroviral resistance: scientific principles and clinical applicationsDrugs2012729e1e2510.2165/11633630-000000000-0000022686620
   PubMed Web of Science ®Google Scholar
• FerreyraCYunOEisenbergNEvaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, KenyaPLoS One2012711e4983410.1371/journal.pone.004983423185450
   PubMed Web of Science ®Google Scholar
• ArnedoMAlonsoEEisenbergNMonitoring HIV viral load in resource limited settings: still a matter of debate?PLoS One2012712e4739110.1371/journal.pone.004739123236346
   PubMed Web of Science ®Google Scholar
• IngoleNMehtaPPazareAParanjpeSSarkatePPerformance of immunological response in predicting virological failureAIDS Res Hum Retroviruses201329354154610.1089/aid.2012.026623137294
   PubMed Web of Science ®Google Scholar
• Medina LaraAKigoziJAmurwonJDART Trial TeamCost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and ZimbabwePLoS One201274e3367210.1371/journal.pone.003367222545079
   PubMed Web of Science ®Google Scholar
• StoverJKorenrompELBlakleyMLong-term costs and health impact of continued global fund support for antiretroviral therapyPLoS One201166e2104810.1371/journal.pone.002104821731646
   PubMed Web of Science ®Google Scholar
• BoyerSMarchLKouanfackCStratall ANRS 12110/ESTHER Study GroupMonitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysisLancet Infect Dis201313757758610.1016/S1473-3099(13)70073-223602084
   PubMed Web of Science ®Google Scholar
• Tayler-SmithKZachariahRMassaquoiMUnacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system?Trans R Soc Trop Med Hyg2010104531331910.1016/j.trstmh.2010.01.00720138323
   PubMed Web of Science ®Google Scholar
• GovindasamyDFordNKranzerKRisk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic reviewAIDS201226162059206710.1097/QAD.0b013e3283578b9b22781227
   PubMed Web of Science ®Google Scholar
• GovindasamyDvan SchaikNKranzerKWoodRMathewsCBekkerLGLinkage to HIV care from a mobile testing unit in South Africa by different CD4 count strataJ Acquir Immune Defic Syndr201158334435210.1097/QAI.0b013e31822e0c4c21836524
   PubMed Web of Science ®Google Scholar
• ZachariahRReidSDChailletPMassaquoiMSchoutenEJHarriesADViewpoint: why do we need a point-of-care CD4 test for low-income countries?Trop Med Int Health2011161374110.1111/j.1365-3156.2010.02669.x21371207
   PubMed Web of Science ®Google Scholar
• LaursenLPoint-of-care tests poised to alter course of HIV treatmentNat Med2012188115610.1038/nm0812-115622869167
   PubMed Web of Science ®Google Scholar
• PeelingRWHolmesKKMabeyDRonaldARapid tests for sexually transmitted infections (STIs): the way forwardSex Transm Infect2006825v1v610.1136/sti.2006.02426517151023
   PubMed Web of Science ®Google Scholar
• KitahataMMGangeSJAbrahamAGEffect of early versus deferred antiretroviral therapy for HIV on survivalN Engl J Med2009360181815182610.1056/NEJMoa080725219339714
   PubMed Web of Science ®Google Scholar
• SpacekLAShihabHMLutwamaFEvaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and UgandaJ Acquir Immune Defic Syndr200641560761010.1097/01.qai.0000214807.98465.a216652034
   PubMed Web of Science ®Google Scholar
• The CD4 Initiative [webpage on the Internet]LondonImperial College London2006 Available from: http://www3.imperial.ac.uk/cd4Accessed May 2, 2013
   Google Scholar
• SukapiromKOnlamoonNThepthaiCPolsrilaKTassaneetrithepBPattanapanyasatKPerformance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settingsJ Acquir Immune Defic Syndr201158214114710.1097/QAI.0b013e31822866a221709568
   PubMed Web of Science ®Google Scholar
• JaniIVSitoeNEChongoPLAccurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testingAIDS201125680781210.1097/QAD.0b013e328344f42421378535
   PubMed Web of Science ®Google Scholar
• BornheimerSBuiNLeDDevelopment of the BD FACSPresto instrument, a new point-of-care system for CD4⁺ countingIAS 2013June 30–July 3, 2013Kuala Lumpur, Malaysia Available at http://pag.ias2013.org/Abstracts.aspx?AID=1471Accessed August 1, 2013
   Google Scholar
• EstillJEggerMBlaserNIeDEA Southern AfricaCost-effectiveness of point-of-care viral load monitoring of ART in resource-limited settings: mathematical modelling studyAIDS Epub34201310.1097/QAD.0b013e328360a4e5
   Web of Science ®Google Scholar
• UrdeaMPennyLAOlmstedSSRequirements for high impact diagnostics in the developing worldNature2006444Suppl 1737910.1038/nature0544817159896
   PubMedGoogle Scholar
• LeeHHDinevaMAChuaYLRitchieAVUshiro-LumbIWisniewskiCASimple amplification-based assay: a nucleic acid based point-of-care platform for HIV-1 testingJournal Infect Dis2010201S65S7210.1086/65038520225949
   PubMed Web of Science ®Google Scholar
• JaniIMeggiBVubilAEvaluation of point-of-care nucleic acid testing for HIV viral load and early infant diagnosis in primary health clinics: MozambiqueAbstract presented at Conference on Retroviruses and Opportunistic Infections2013Atlanta, GAMarch 3–6, 2013
   Google Scholar
• DART Trial TeamMugyenyiPWalkerASRoutine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trialLancet2010375970912313110.1016/S0140-6736(09)62067-520004464
   PubMed Web of Science ®Google Scholar
• BongomeraGNamataHNkhataMLablite: baseline mapping survey of decentralised ART service provision in Malawi, Uganda and ZimbabweConference abstract. 19th International AIDS ConferenceJuly 22–July, 27, 2012Washington DC
   Google Scholar
• GrundyCMedina LaraAWinogronDPoint-of-care CD4 tests can increase life-years saved with reduced costs compared to flow cytometric CD4 countingAbstract presented at the Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention2011Rome
   Google Scholar
• LarsonBASchnippelKNdibongoBRapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South AfricaJ Acquir Immune Defic Syndr2012612e13e1710.1097/QAI.0b013e31825eec6022659650
   PubMed Web of Science ®Google Scholar
• JaniIVSitoeNEAlfaiEREffect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort studyLancet201137898021572157910.1016/S0140-6736(11)61052-021951656
   PubMed Web of Science ®Google Scholar
• MuchedziAChadambukaAChikwinyaBMahomvaAEvaluating the effect of the use of point-of-care CD4 machines on access to anti-retroviral therapy (ART) eligibility screening and ART initiation for HIV-positive pregnant women in Zimbabwe: towards elimination of new paediatric HIV infection by 2015J Int AIDS Soc201215282282
   Web of Science ®Google Scholar
  Abstract presented at IASJuly 22–27; 2012Washington, DC, USA
   Google Scholar
• HatzoldKGudukeyaSBMusetaMImproved access to HAART through point of care CD4 cell count testing integration into HIV testing and counseling services in Zimbabwe6th IAS Conference on HIV Pathogenesis and Treatment2011Rome Conference AbstractJuly 17–July 20, 2011
   Google Scholar
• CiaranelloALMyerLChristensenSThe cost-effectiveness of point-of-care CD4 testing in antenatal care in South AfricaAbstract presented at Conference on Retroviruses and Opportunistic Infections2013Atlanta, GAMarch 3–6, 2013
   Google Scholar